Isolation of side population cells in B-cell non-Hodgkin's lymphomas

Acta Haematologica

Volumn 129, Issue 1, 2013, Pages 10-17

  Lee, Mi Ran ^a   Ju, Hyun Jeong ^a   Kim, Byung Soo ^b   Ko, Young Hyeh ^c   Kim, Won Seog ^c   Kim, Seok Jin ^c  

^a Samsung Medical Center   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

B cell lymphoma; Cancer stem cells; Non Hodgkin's lymphoma; Side population; Stem cell like factors

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; COMPLEMENTARY DNA; OCTAMER TRANSCRIPTION FACTOR 4; TELOMERASE; TRANSCRIPTION FACTOR NANOG; DOXORUBICIN; ETOPOSIDE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL ISOLATION; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; DNA MICROARRAY; DRUG RESISTANCE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIDE POPULATION CELL; B CELL LYMPHOMA; B CELL LYMPHOMA CELL; CANCER RESISTANCE; CANCER STEM CELL; DRUG SENSITIVITY; PRIMARY CELL;

APOPTOSIS; ATP-BINDING CASSETTE TRANSPORTERS; CELL SURVIVAL; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION PROFILING; HOMEODOMAIN PROTEINS; HUMANS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; SIDE-POPULATION CELLS; TELOMERASE; TUMOR CELLS, CULTURED;

EID: 84865844357     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000341284     Document Type: Article

References (32)

1. Reya T, Morrison SJ, Clarke MF, Weissman IL: Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-111 (Pubitemid 33041634)
2. Wang JC, Dick JE: Cancer stem cells: Lessons from leukemia. Trends Cell Biol 2005; 15: 494-501 (Pubitemid 41253469)
3. Visvader JE, Lindeman GJ: Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions. Nat Rev Cancer 2008; 8: 755-768
4. Warner JK, Wang JC, Hope KJ, Jin L, Dick JE: Concepts of human leukemic development. Oncogene 2004; 23: 7164-7177 (Pubitemid 39382151)
5. Al-Hajj M, Clarke MF: Self-renewal and solid tumor stem cells. Oncogene 2004; 23: 7274-7282 (Pubitemid 39382161)
6. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB: Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401 (Pubitemid 39551674)
7. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R: Identification and expansion of human colon- cancer-initiating cells. Nature 2007; 445: 111-115 (Pubitemid 46067311)
8. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ, Heeschen C: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007; 1: 313-323 (Pubitemid 47355323)
9. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005; 65: 10946-10951 (Pubitemid 41713363)
10. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC: Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996; 183: 1797-1806 (Pubitemid 26134320)
11. Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M, Nakauchi H, Sorrentino BP: The ABC transporter BCRP1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 2001; 7: 1028- 1034 (Pubitemid 32937383)
12. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F, Maclaughlin DT, Donahoe PK: Ovarian cancer side population defines cells with stem cell-like characteristics and mullerian inhibiting substance responsiveness. Proc Natl Acad Sci USA 2006; 103: 11154-11159 (Pubitemid 44156488)
13. Sung JM, Cho HJ, Yi H, Lee CH, Kim HS, Kim DK, Abd El-Aty AM, Kim JS, Landowski CP, Hediger MA, Shin HC: Characterization of a stem cell population in lung cancer A549 cells. Biochem Biophys Res Commun 2008; 371: 163-167
14. Fukuda K, Saikawa Y, Ohashi M, Kumagai K, Kitajima M, Okano H, Matsuzaki Y, Kitagawa Y: Tumor initiating potential of side population cells in human gastric cancer. Int J Oncol 2009; 34: 1201-1207
15. Murase M, Kano M, Tsukahara T, Takahashi A, Torigoe T, Kawaguchi S, Kimura S, Wada T, Uchihashi Y, Kondo T, Yamashita T, Sato N: Side population cells have the characteristics of cancer stem-like cells/cancer-initiating cells in bone sarcomas. Br J Cancer 2009; 101: 1425-1432
16. Martinez-Climent JA, Fontan L, Gascoyne RD, Siebert R, Prosper F: Lymphoma stem cells: Enough evidence to support their existencë Haematologica 2010; 95: 293-302
17. Kim SJ: Lymphoma stem cells: A step toward a new therapeutic target. Korean J Hematol 2011; 46: 211-213
18. Vega F, Davuluri Y, Cho-Vega JH, Singh RR, Ma S, Wang RY, Multani AS, Drakos E, Pham LV, Lee YC, Shen L, Ambrus J Jr, Medeiros LJ, Ford RJ: Side population of a murine mantle cell lymphoma model contains tumour-initiating cells responsible for lymphoma maintenance and dissemination. J Cell Mol Med 2010; 14: 1532-1545
19. Masters JR: Human cancer cell lines: Fact and fantasy. Nat Rev Mol Cell Biol 2000; 1: 233- 236
20. van Staveren WC, Solis DY, Hebrant A, Detours V, Dumont JE, Maenhaut C: Human cancer cell lines: Experimental models for cancer cells in sitüFor cancer stem cells? Biochim Biophys Acta 2009; 1795: 92-103
21. Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J, Nikolskaya T, Serebryiskaya T, Beroukhim R, Hu M, Halushka MK, Sukumar S, Parker LM, Anderson KS, Harris LN, Garber JE, Richardson AL, Schnitt SJ, Nikolsky Y, Gelman RS, Polyak K: Molecular definition of breast tumor heterogeneity. Cancer Cell 2007; 11: 259-273 (Pubitemid 46349843)
22. Fletcher JI, Haber M, Henderson MJ, Norris MD: ABC transporters in cancer: More than just drug efflux pumps. Nat Rev Cancer 2010; 10: 147-156
23. Yoh K, Ishii G, Yokose T, Minegishi Y, Tsuta K, Goto K, Nishiwaki Y, Kodama T, Suga M, Ochiai A: Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer. Clin Cancer Res 2004; 10: 1691- 1697 (Pubitemid 38435560)
24. Damm F, Oberacker T, Thol F, Surdziel E, Wagner K, Chaturvedi A, Morgan M, Bomm K, Gohring G, Lubbert M, Kanz L, Fiedler W, Schlegelberger B, Heil G, Schlenk RF, Dohner K, Dohner H, Krauter J, Ganser A, Heuser M: Prognostic importance of histone methyltransferase MLL5 expression in acute myeloid leukemia. J Clin Oncol 2011; 29: 682- 689
25. Zhao Y, Fei M, Wang Y, Lu M, Cheng C, Shen A: Expression of Foxo3a in non-Hodgkin's lymphomas is correlated with cell cycle inhibitor p27. Eur J Haematol 2008; 81: 83-93 (Pubitemid 352019627)
26. Obrador-Hevia A, Serra-Sitjar M, Rodriguez J, Villalonga P, de Mattos SF: The tumour suppressor FOXO3 is a key regulator of mantle cell lymphoma proliferation and survival. Br J Haematol 2012; 156: 334-345
27. Karube K, Nakagawa M, Tsuzuki S, Takeuchi I, Honma K, Nakashima Y, Shimizu N, Ko YH, Morishima Y, Ohshima K, Nakamura S, Seto M: Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses. Blood 2011; 118: 3195- 3204
28. Ploner C, Rainer J, Niederegger H, Eduardoff M, Villunger A, Geley S, Kofler R: The BCL2 rheostat in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia. Leukemia 2008; 22: 370-377 (Pubitemid 351250542)
29. Jin HO, Seo SK, Woo SH, Kim YS, Hong SE, Yi JY, Noh WC, Kim EK, Lee JK, Hong SI, Choe TB, Park IC: Redd1 inhibits the invasiveness of non-small cell lung cancer cells. Biochem Biophys Res Commun 2011; 407: 507-511
30. Ben Sahra I, Regazzetti C, Robert G, Laurent K, Le Marchand-Brustel Y, Auberger P, Tanti JF, Giorgetti-Peraldi S, Bost F: Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1 Cancer Res 2011; 71: 4366-4372
31. Chen Z, Ayala P, Wang M, Fayad L, Katz RL, Romaguera J, Caraway N, Neelapu SS, Kwak LW, Simmons PJ, McCarty N: Prospective isolation of clonogenic mantle cell lymphoma- initiating cells. Stem Cell Res 2010; 5: 212-225
32. Jung HJ, Chen Z, McCarty N: Stem-like tumor cells confer drug resistant properties to mantle cell lymphoma. Leuk Lymphoma 2011; 52: 1066-1079